Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Track and trace
03 June, 2022
There is nothing like a pandemic for demonstrating the necessity...
> read more

Outsource and intake 03 June, 2022 For decades, pharmaceutical companies have relied on contract development and manufacturing companies (CDMOs) to develop drugs. But though these third-party contractors proved their...

Double agents 03 June, 2022 Looking at a vial of liquid or a solid pill, it’s easy to see pharmaceuticals as simple objects rather than a complex array of chemicals and raw materials, delicately balanced to...

The struggle to supply 03 June, 2022 Pharmaceutical supply chains are still reacting to the pressures of the pandemic, though they have mostly held steady and avoided many of the potential risks. The stresses placed...

Good things, small packages 03 June, 2022 Containers have been an inescapable part of the pharma supply chain forever – but it’s only with the rise of sophisticated new treatments, and the consequences of the pandemic,...

A glass act 03 June, 2022 Glass has been the most popular primary packaging choice for drug makers for centuries, a combination of its formulation compatibility and low permeability. But the choice of...

Better sterile than sorry 03 June, 2022 Sterility throughout the manufacturing process is something no pharmaceutical company can overlook, both from a regulatory and a customer care standpoint. That said, the actual...

The digital health game 03 June, 2022 Some of the most ground-breaking results come when technologies are combined with the same ambition in mind. Advances in pharmaceuticals will continue to change people’s lives,...

Down the hatch 03 June, 2022 Vaccination continues to be our best defence against the morbidity and mortality caused by Covid-19, but with the imperative to ‘boost’ the number of antibodies by giving multiple...

Subject to requirements 28 January, 2022 Clinical trial materials each have unique packaging requirements, and there are also a number of processes and systems to consider that can help to minimise delays and ensure a...

Choosing the right central lab 28 January, 2022 Central laboratories have become an important part of running global clinical trials in Europe and the US. With the rapid increase in the number of studies conducted in China and...

Rise to the challenge 28 January, 2022 Running a clinical trial can be a difficult process at the best of times, but the level of complexity can be orders of magnitude higher when it comes to rare disease research....

Clinical trials and tribulations 28 January, 2022 Even though they’re often a vital conduit between the drug and patient, ancillary supplies are sometimes seen as an afterthought for sponsors, who have been known to request items at...

Cash in on opportunity 28 January, 2022 Adaptive trial designs have enabled clinical research to keep up with Covid-19, but their operational costs and complexities might be harder to justify once the pandemic has passed...

Trial at home 28 January, 2022 Clinical trials have historically been done at hospitals or clinics, with subjects and researchers convening to get results. But with the rise of new technology – to say nothing of...

Next-gen vaccines 28 January, 2022 The lockdowns of 2020 and beyond led to economic disruption on a scale not seen outside of wartime, and the imperative to reduce some of this damage led to the fastest vaccines...

Reap the benefits 28 January, 2022 Clinical study protocols are important cornerstones on the journey of collecting the clinical data needed to elucidate the benefit-risk profile of medical treatments/devices....

The smart money 28 December, 2021 Smart packaging offers huge value to the whole of the supply chain. There are a number of recent innovations that can help optimise monitoring. Louise Thomas speaks to Ruud van der...

Counterfeit and proper 28 December, 2021 The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...

Waste not, want not 28 December, 2021 The health sector is responsible for an estimated 4.4% of global greenhouse gas emissions – the vast majority of which originate in the supply chain. One of the easiest ways to...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.